Latest Videos

Prof. Martin Farlow, esteemed member of the US Neurology Editorial Board, discusses the use of antipsychotics in adults with dementia, and the benefit of tau imaging in the diagnosis of Alzheimers. Pa...
Prof. Martin Farlow, esteemed member of the US Neurology Editorial Board, discusses the recent clinical trial of solanezumab in Alzheimer's disease and the current treatment landscape. Part 1 of 2. Vi...
We met with Dr Jeff Cummings, from the US Neurology Editorial Board, to discuss the current treatment landscape in Alzheimer’s disease, and recent clinical trials for new drugs. Speaker disclosures...
Dennis J. Selkoe, MD, Co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, discusses progress in the development of Alzheimer’s disease treatments that target...
Since the time of Dr. Alois Alzheimer himself, two proteins (beta-amyloid (Aβ) and tau) have become tantamount to Alzheimer's disease (AD). But a Mayo Clinic study challenges the perception that these...
With an aging population medical concerns also are on the rise especially for patients with dementia. A recent study has looked at whether coagulants play a part in patients with atrial fibrillation d...
As the population continues to age and more and more people are diagnosed with Alzheimer's Disease or some other form of dementia researchers are looking into what can be done to stem the tide of furt...
The field of research for alzheimer's disease has changed drastically in just over a year as more is learned about amyloids and their role in patients developing the condition.
By examining more than 3,600 postmortem brains, researchers at Mayo Clinic’s campuses in Jacksonville, Florida, and Rochester, Minnesota, have found that the progression of dysfunctional tau protein d...
Glenn E. Smith, Ph.D., L.P., Neuropsychologist & Professor of Psychology, Mayo Clinic, discusses his work with a team that is identifying conditions which may eventually turn into dementia.